Last reviewed · How we verify
NCT02370771: PASEO
Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis
NA trial testing Biological sampling in Erosive Hand Osteoarthritis in 32 participants. Completed in 17 November 2019.
17 November 2019
Quick facts
| Lead sponsor | University Hospital, Rouen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 32 |
| Start date | 9 June 2015 |
| Primary completion | 17 November 2019 |
| Estimated completion | 17 November 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Biological sampling — full drug profile →
- Radiographic evaluation — full drug profile →
Conditions studied
- Erosive Hand Osteoarthritis — all drugs for Erosive Hand Osteoarthritis →
Sponsor
University Hospital, Rouen
Who can join
Adults 18 to 70, female only, with Erosive Hand Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hand osteoarthritis is a common phenotype of osteoarthritis which affects about 70 % of the elderly population. Usually considered as a minor illness, it nevertheless leads to an important functional impairment. The mechanism of this disease is still poorly known. Furthermore there are 2 different subtypes : erosive and non erosive hand osteoarthritis from which mechanisms may differ. Methods: This is a cross-sectional study recruiting patients with hand osteoarthritis addressed in consultation of rheumatology and plastic surgery in Rouen University Hospital. Two groups of patients will be studied: 20 patients with non erosive subtype of hand osteoarthritis and 20 patients with erosive subtype of hand osteoarthritis. A clinical evaluation of hand osteoarthritis will be performed. Blood sample for proteomic analysis will be taken. Hand MRI and Bone Mineral Analyser will be performed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02370771
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biological sampling
Trials testing the same drug.
- NCT05970965 — Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples · NA · recruiting
- NCT06890078 — Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients · not yet recruiting
- NCT06828458 — Determining Elements of Anti-Fungal Immunity in BURN Patients · not yet recruiting
- NCT06690151 — Characterization and Support of Neurodevelopmental Disorders Associated With Congenital Cardiac malfoRmations - Neonatal · recruiting
- NCT07017348 — Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis · NA · completed
Other University Hospital, Rouen trials
Trials by the same sponsor.
- NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
- NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
- NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
- NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
- NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02370771 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
- Last refreshed: 30 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02370771.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing